FBXO11 gene silencing led to the development of diffuse large B-cell lymphoma (DLBCL) by targeting the degradation of Bcl-6 [26], while FBXO11 inactivation resulted in abnormal germinal-centre formation. Here, FBXO11 is linked to diffuse large B-cell lymphoma.